← FDA DRUG APPROVALS

FDA ANDA · ANDA076878

METFORMIN HYDROCHLORIDE

Sponsor: ACTAVIS ELIZABETH

APPLICATION
ANDA076878
TYPE
ANDA
ORIGINAL APPROVAL
2005-04-13
LATEST ACTION
2026-07-14
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

METFORMIN HYDROCHLORIDEDiscontinued
METFORMIN HYDROCHLORIDE 750MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2026-07-14Labeling · Supplement 16 · standardAP
2026-07-14Labeling · Supplement 15 · standardAP
2008-12-22Labeling · Supplement 12AP
2005-04-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →